There’s no such thing as "natural Ozempic." While supplements like psyllium, berberine, and glucomannan are paraded as ...

ALONG with rapid fat loss, weight loss jabs have been linked to a decrease in muscle mass. But scientists say one injection – ...

In today’s world, losing weight isn’t just about fitting into your old jeans—it’s about reclaiming your energy, confidence, ...

Weight-loss drugs offer initial benefits but often lead to weight regain after discontinuation. Bariatric surgery provides lasting metabolic changes and better long-term health outcomes for obesity ...

A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with overweight or obesity, outperforming liraglutide and placebo. Brain ...

The jab has been rolled out in a bid to tackle climbing obesity levels and support individuals returning to work ...

Common side effects include nausea, vomiting, diarrhea, constipation, stomach pain, decreased appetite, and indigestion. Mounjaro is not recommended for children under 18 years of age, and its safety ...

Appetite suppressants can help you reduce your calorie intake, but for best results, they should be combined with regular movement, nutritious foods, plenty of water, and adequate sleep.

With its dual-targeting mechanism acting on both GLP-1 and GIP receptors, tirzepatide appears to provide more robust appetite regulation and fat metabolism.

Both medications are part of a newer class of drugs that act on hormone receptors involved in appetite regulation. Tirzepatide targets two receptors (GIP and GLP-1), while semaglutide targets only one ...

Eli Lilly and Company announced detailed results from SURMOUNT-5, a phase 3b open-label clinical trial, evaluating the safety and efficacy of tirzepatide, a dual GIP and GLP-1 receptor agonist, ...